UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Blocking Indolamine-2,3-Dioxygenase Rebound Immune Suppression Boosts Antitumor Effects of Radio-Immunotherapy in Murine Models and Spontaneous Canine Malignancies

Clinical cancer research, 2016-09, Vol.22 (17), p.4328-4340

2016

Volltextzugriff (PDF)

Utilizing immunogenomic approaches to prioritize targetable neoantigens for personalized cancer immunotherapy

Frontiers in immunology, 2023-12, Vol.14, p.1301100-1301100

2023

Volltextzugriff (PDF)

Aging predisposes to acute inflammatory induced pathology after tumor immunotherapy

The Journal of experimental medicine, 2013-10, Vol.210 (11), p.2223-2237

2013

Volltextzugriff (PDF)

Genome-wide CRISPR screen reveals PSMA6 to be an essential gene in pancreatic cancer cells

BMC cancer, 2019-03, Vol.19 (1), p.253-12, Article 253

2019

Volltextzugriff (PDF)

Hitting the Target: How T Cells Detect and Eliminate Tumors

The Journal of immunology (1950), 2018-01, Vol.200 (2), p.392-399

2018

Volltextzugriff (PDF)

Bystander activation and anti-tumor effects of CD8+ T cells following Interleukin-2 based immunotherapy is independent of CD4+ T cell help

PloS one, 2014-08, Vol.9 (8), p.e102709-e102709

2014

Volltextzugriff (PDF)

Current advances in experimental and computational approaches to enhance CAR T cell manufacturing protocols and improve clinical efficacy

Frontiers in Molecular Medicine, 2024-02, Vol.4, p.1310002

2024

Volltextzugriff (PDF)

Transcription factor ZNF148 is a negative regulator of human muscle differentiation

Scientific reports, 2017-08, Vol.7 (1), p.8138-10, Article 8138

2017

Volltextzugriff (PDF)

Tumor-intrinsic and -extrinsic determinants of response to blinatumomab in adults with B-ALL

Blood, 2021-01, Vol.137 (4), p.471-484

2021

Volltextzugriff (PDF)

SNP-mediated disruption of CTCF binding at the IFITM3 promoter is associated with risk of severe influenza in humans

Nature medicine, 2017-08, Vol.23 (8), p.975-983

2017

Volltextzugriff (PDF)

Lung γδ T Cells Mediate Protective Responses during Neonatal Influenza Infection that Are Associated with Type 2 Immunity

Immunity (Cambridge, Mass.), 2018-09, Vol.49 (3), p.531-544.e6

2018

Volltextzugriff (PDF)

Cell-Intrinsic Barriers of T Cell-Based Immunotherapy

Trends in molecular medicine, 2016-12, Vol.22 (12), p.1000-1011

2016

Volltextzugriff (PDF)

Immunoediting and antigen loss: overcoming the achilles heel of immunotherapy with antigen non-specific therapies

Frontiers in oncology, 2013-01, Vol.3, p.197-197

2013

Volltextzugriff (PDF)

Pediatric patients with acute lymphoblastic leukemia generate abundant and functional neoantigen-specific CD8 + T cell responses

Science translational medicine, 2019-06, Vol.11 (498)

2019

Volltextzugriff (PDF)

Type 2 cannabinoid receptor expression on microglial cells regulates neuroinflammation during graft-versus-host disease

The Journal of clinical investigation, 2024-06, Vol.134 (11), p.1-18

2024

Volltextzugriff (PDF)

Widening demographic gaps in CAR-T therapy utilization for multiple myeloma in the United States

Bone marrow transplantation (Basingstoke), 2023-12, Vol.58 (12), p.1400-1402

2023

Volltextzugriff (PDF)

Influenza infection results in local expansion of memory CD8+ T cells with antigen non‐specific phenotype and function

Clinical and experimental immunology, 2014-01, Vol.175 (1), p.79-91

2014

Volltextzugriff (PDF)

Murine NK-cell licensing is reflective of donor MHC-I following allogeneic hematopoietic stem cell transplantation in murine cytomegalovirus responses

Blood, 2013-08, Vol.122 (8), p.1518-1521

2013

Volltextzugriff (PDF)

Antigen cross-presentation in young tumor-bearing hosts promotes CD8 + T cell terminal differentiation

Science immunology, 2022-02, Vol.7 (68), p.eabf6136

2022

Volltextzugriff (PDF)

DNAJB1-PRKACA fusion neoantigens elicit rare endogenous T cell responses that potentiate cell therapy for fibrolamellar carcinoma

Cell reports. Medicine, 2024-03, Vol.5 (3), p.101469-101469, Article 101469

2024

Volltextzugriff (PDF)

Models to Study NK Cell Biology and Possible Clinical Application

Current Protocols in Immunology, 2015-08, Vol.110 (1), p.14.37.1-14.37.14

2015

Volltextzugriff (PDF)

Activation status dictates the function of unlicensed natural killer cells in mice and humans

Blood advances, 2021-10, Vol.5 (20), p.4219-4232

2021

Volltextzugriff (PDF)

Licensing delineates helper and effector NK cell subsets during viral infection

JCI insight, 2017-05, Vol.2 (10)

2017

Volltextzugriff (PDF)

Chimeric Antigen Receptor-T (CAR-T) Cell Therapy Targeting BCMA in Patients with Prior Allogeneic Transplantation (allo-HCT) in Relapsed and/or Refractory Multiple Myeloma (RRMM)

Blood, 2022-11, Vol.140 (Supplement 1), p.7215-7216

2022

Volltextzugriff (PDF)

CD8 T cell responses to conserved DNAJB1-PRKACA fusion neoantigens in fibrolamellar carcinoma

The Journal of immunology (1950), 2022-05, Vol.208 (1_Supplement), p.121-121.06

2022

Volltextzugriff (PDF)

1 – 25 von 129

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(104)
Mit Volltextzugriff
(96)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Blocking Indolamine-2,3-Dioxygenase Rebound Immune Suppression Boosts Antitumor Effects of Radio-Immunotherapy in Murine Models and Spontaneous Canine Malignancies

Utilizing immunogenomic approaches to prioritize targetable neoantigens for personalized cancer immunotherapy

Aging predisposes to acute inflammatory induced pathology after tumor immunotherapy

Genome-wide CRISPR screen reveals PSMA6 to be an essential gene in pancreatic cancer cells

Hitting the Target: How T Cells Detect and Eliminate Tumors

Bystander activation and anti-tumor effects of CD8+ T cells following Interleukin-2 based immunotherapy is independent of CD4+ T cell help

Current advances in experimental and computational approaches to enhance CAR T cell manufacturing protocols and improve clinical efficacy

Transcription factor ZNF148 is a negative regulator of human muscle differentiation

Tumor-intrinsic and -extrinsic determinants of response to blinatumomab in adults with B-ALL

SNP-mediated disruption of CTCF binding at the IFITM3 promoter is associated with risk of severe influenza in humans

Lung γδ T Cells Mediate Protective Responses during Neonatal Influenza Infection that Are Associated with Type 2 Immunity

Cell-Intrinsic Barriers of T Cell-Based Immunotherapy

Immunoediting and antigen loss: overcoming the achilles heel of immunotherapy with antigen non-specific therapies

Pediatric patients with acute lymphoblastic leukemia generate abundant and functional neoantigen-specific CD8 + T cell responses

Type 2 cannabinoid receptor expression on microglial cells regulates neuroinflammation during graft-versus-host disease

Widening demographic gaps in CAR-T therapy utilization for multiple myeloma in the United States

Influenza infection results in local expansion of memory CD8+ T cells with antigen non‐specific phenotype and function

Murine NK-cell licensing is reflective of donor MHC-I following allogeneic hematopoietic stem cell transplantation in murine cytomegalovirus responses

Antigen cross-presentation in young tumor-bearing hosts promotes CD8 + T cell terminal differentiation

DNAJB1-PRKACA fusion neoantigens elicit rare endogenous T cell responses that potentiate cell therapy for fibrolamellar carcinoma

Models to Study NK Cell Biology and Possible Clinical Application

Activation status dictates the function of unlicensed natural killer cells in mice and humans

Licensing delineates helper and effector NK cell subsets during viral infection

Chimeric Antigen Receptor-T (CAR-T) Cell Therapy Targeting BCMA in Patients with Prior Allogeneic Transplantation (allo-HCT) in Relapsed and/or Refractory Multiple Myeloma (RRMM)

CD8 T cell responses to conserved DNAJB1-PRKACA fusion neoantigens in fibrolamellar carcinoma

Suchergebnisse filtern